Utilization of the Pancreas From Donors With an Extremely High Pancreas Donor Risk Index: Report of the National Registry of Pancreas Transplantation

Pancreas transplants from expanded criteria donors are performed widely in Japan because there is a shortage of brain-dead donors. However, the effectiveness of this strategy is unknown. We retrospectively studied 371 pancreas transplants to evaluate the possibility of pancreas transplantation from expanded criteria donors by the Pancreas Donor Risk Index (PDRI). Patients were divided into five groups according to quintiles of PDRI values (Q1–Q5). The 1-year pancreas graft survival rates were 94.5% for Q1, 91.9% for Q2, 90.5% for Q3, 89.3% for Q4, and 79.6% for Q5, and were significantly lower with a lower PDRI (p = 0.04). A multivariate analysis showed that the PDRI, donor hemoglobin A1c values, and pancreas transplantation alone significantly predicted 1-year pancreas graft survival (all p < 0.05). Spline curve analysis showed that the PDRI was incrementally associated with an increased risk of 1-year graft failure. In the group with a PDRI ≥ 2.87, 8/56 patients had graft failures within 1 month, and all were due to graft thrombosis. The PDRI is a prognostic factor related to the 1-year graft survival rate. However, pancreas transplantation from high-PDRI donors shows acceptable results and could be an alternative when the donor pool is insufficient. Graphical Abstract

[1]  T. Jenssen,et al.  Validating the US pancreas donor risk index in a Norwegian population, a retrospective observational study , 2022, Scandinavian journal of gastroenterology.

[2]  P. Friend,et al.  Pancreas utilization rates in the UK – an 11‐year analysis , 2021, Transplant international : official journal of the European Society for Organ Transplantation.

[3]  H. Eguchi,et al.  Current state of pancreas transplantation in Japan based on the nationwide registry , 2021, Annals of gastroenterological surgery.

[4]  H. Eguchi,et al.  Clinical impact of pancreas donor age on outcomes following pancreas transplantation: Analysis of a nationwide registry in Japan. , 2021, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[5]  Toshinori Ito,et al.  Are the outcomes of Japanese pancreas transplantation utilizing extended‐criteria donors acceptable? A propensity score matching analysis for donors <50 or ≥50 years old , 2020, Transplant international : official journal of the European Society for Organ Transplantation.

[6]  R. Pol,et al.  Risk analysis of extended pancreas donor selection criteria. , 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[7]  G. Elder,et al.  Health‐related quality of life following kidney and simultaneous pancreas kidney transplantation , 2019, Nephrology.

[8]  M. Büchler,et al.  The Role of Pre-Procurement Pancreas Suitability Score (P-PASS) and Pancreas Donor Risk Index (PDRI) in the Outcome of Simultaneous Pancreas and Kidney or Pancreas After Kidney Transplantation , 2019, Annals of transplantation.

[9]  R. Viebahn,et al.  Pancreas Donor Risk Index but Not Pre-Procurement Pancreas Allocation Suitability Score Predicts Pancreas Graft Survival: A Cohort Study from a Large German Pancreas Transplantation Center , 2018, Annals of transplantation.

[10]  Pawel Skrzypek,et al.  Usefulness of Pancreas Donor Risk Index and Pre-Procurement Pancreas Allocation Suitability Score: Results of the Polish National Study , 2018, Annals of transplantation.

[11]  K. Lentine,et al.  Selected Mildly Obese Donors Can Be Used Safely in Simultaneous Pancreas and Kidney Transplantation , 2017, Transplantation.

[12]  J. Ruiz-Rabelo,et al.  Validation of the Pancreatic Donor Risk Index in Simultaneous Pancreas-Kidney Transplantation Performed in Córdoba Hospital From 2000 to 2015. , 2016, Transplantation proceedings.

[13]  H. Putter,et al.  The Value of PDRI and P-PASS as Predictors of Outcome After Pancreas Transplantation in a Large European Pancreas Transplantation Center , 2016, Pancreas.

[14]  P. Friend,et al.  Validation of the Pancreas Donor Risk Index for use in a UK population , 2015, Transplant international : official journal of the European Society for Organ Transplantation.

[15]  D. Schaubel,et al.  A Reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation , 2015, Transplantation.

[16]  K. Kaku,et al.  Living donor kidney transplantation preceding pancreas transplantation reduces mortality in type 1 diabetics with end-stage renal disease. , 2015, Transplantation proceedings.

[17]  Anabela S Rodrigues,et al.  Health‐related quality of life may improve after transplantation in pancreas–kidney recipients , 2015, Clinical transplantation.

[18]  P. Friend,et al.  App to reality: snapshot validation of the US Pancreas Donor Risk Index in a UK center. , 2013, The Journal of surgical research.

[19]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[20]  R. Wolfe,et al.  Systematic Evaluation of Pancreas Allograft Quality, Outcomes and Geographic Variation in Utilization , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  R. Gruessner,et al.  Mortality Assessment for Pancreas Transplants , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  R. Kandaswamy,et al.  Technical Failures after Pancreas Transplants: Why Grafts Fail and the Risk Factors—A Multivariate Analysis , 2004, Transplantation.

[23]  R. Kandaswamy,et al.  The Impact of Donor Obesity on Outcomes after Cadaver Pancreas Transplants , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  D. Heisey,et al.  Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? , 2000, Annals of surgery.

[25]  R. Kandaswamy,et al.  Decreased surgical risks of pancreas transplantation in the modern era. , 2000, Annals of surgery.

[26]  D. Dunn,et al.  The surgical risk of pancreas transplantation in the cyclosporine era: an overview. , 1997, Journal of the American College of Surgeons.

[27]  D. Dunn,et al.  Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. , 1996, Journal of the American College of Surgeons.

[28]  A. Gaber,et al.  RISK FACTORS FOR POSTIMPLANTATION PANCREATITIS AND PANCREATIC THROMBOSIS IN PANCREAS TRANSPLANT RECIPIENTS , 1993, Transplantation.

[29]  Pancreas Transplantation – the Asian Experience: A Registry Report , 2022 .

[30]  R. Gruessner,et al.  Pancreas Transplantation of US and Non-US Cases from 2005 to 2014 as Reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). , 2016, The review of diabetic studies : RDS.

[31]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.